AGENUS INC License and Services Revenue (Deprecated 2018-01-31)
AGENUS INC (AGEN) reported License and Services Revenue (Deprecated 2018-01-31) of $22.10 million for the 0-month period ending 2015-02-19, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2018-05-10
- AGENUS INC license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $0.00.
- AGENUS INC license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $0.00.
- AGENUS INC license and services revenue (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $12.80M.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 0 month | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month |
|---|---|---|---|---|
| 2015-02-19 | $22.10M 10-Q · filed 2018-05-10 | |||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $12.80M 10-Q · filed 2013-11-08 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $12.80M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $12.80M 10-Q · filed 2013-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |